Cited by 737Amyotrophic Lateral Sclerosis ResearchNeuroinflammation and Neurodegeneration MechanismsMultiple Sclerosis Research Studies

The DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.

Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study

Open access

Turner, M.R, Cagnin, A, Turkheimer, F.E, Miller, C.C.J, Shaw, C.E, Brooks, D.J, Leigh, P.N, Banati, R.B·2004·Neurobiology of Disease

DOI 10.1016/j.nbd.2003.12.012

Open this paper in CoChat — free account

Abstract

Microglial activation is implicated in the pathogenesis of ALS and can be detected in animal models of the disease that demonstrate increased survival when treated with anti-inflammatory drugs. PK11195 is a ligand for the "peripheral benzodiazepine binding site" expressed by activated microglia. Ten ALS patients and 14 healthy controls underwent [(11)C](R)-PK11195 PET of the brain. Volumes of interest were defined to obtain [(11)C](R)-PK11195 regional binding potential values for motor and "extra-motor" regions. Significantly increased binding was found in motor cortex (P = 0.003), pons (P = 0.004), dorsolateral prefrontal cortex (P = 0.010) and thalamus (P = 0.005) in the ALS patients, with significant correlation between binding in the motor cortex and the burden of upper motor neuron signs clinically (r = 0.73, P = 0.009). These findings indicate that cerebral microglial activation can be detected in vivo during the evolution of ALS, and support the previous observations that cerebral pathology is widespread. They also argue for the development of therapeutic strategies aimed at inflammatory pathways.

Integrity signals

Registry

Crossref · 10.1016/j.nbd.2003.12.012

Cites

90 of 90 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis
Brooks, B. R., Miller, R. G., Swash, M., & Munsat, T. L. (2000) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/146608200300079536 · Cited by 5,433
Mammalian Mitogen-Activated Protein Kinase Signal Transduction Pathways Activated by Stress and Inflammation
Kyriakis, J. M., & Avruch, J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.807 · Cited by 3,400
The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function
Cedarbaum, J. M., Stambler, N., Malta, E., Fuller, C., Hilt, D., Thurmond, B., & Nakanishi, A. (1999) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(99)00210-5 · Cited by 3,307
Simplified Reference Tissue Model for PET Receptor Studies
Lammertsma, A. A., & Hume, S. P. (1996) · NeuroImage · doi:10.1006/nimg.1996.0066 · Cited by 2,025
Amyotrophic Lateral Sclerosis
Rowland, L. P., & Shneider, N. A. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105313442207 · Cited by 1,913
From charcot to lou gehrig: deciphering selective motor neuron death in als
Cleveland, D. W., & Rothstein, J. D. (2001) · Nature reviews. Neuroscience · doi:10.1038/35097565 · Cited by 1,389
Parametric Imaging of Ligand-Receptor Binding in PET Using a Simplified Reference Region Model
Gunn, R. N., Lammertsma, A. A., Hume, S. P., & Cunningham, V. J. (1997) · NeuroImage · doi:10.1006/nimg.1997.0303 · Cited by 1,085
Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice
Zhu, S., Stavrovskaya, I. G., Drozda, M., Kim, B. Y. S., Ona, V. O., Li, M., Sarang, S. S., Liu, A. S., Hartley, D. M., Wu, D. C., et al. (2002) · Nature · doi:10.1038/417074a · Cited by 1,069
In-vivo measurement of activated microglia in dementia
Cagnin, A., Brooks, D. J., Kennedy, A. M., Gunn, R. N., Myers, R., Turkheimer, F. E., Jones, T., & Banati, R. B. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05625-2 · Cited by 1,054
Self-citation
The overlap of amyotrophic lateral sclerosis and frontotemporal dementia
Lomen, C. E., Anderson, T. T., & Miller, B. L. (2002) · Neurology · doi:10.1212/wnl.59.7.1077 · Cited by 699

Show all 90 references

Sorted by citations

Items 301–400 of 737

Tumor Necrosis Factor Alpha in Amyotrophic Lateral Sclerosis: Friend or Foe?
Guidotti, G., Scarlata, C., Brambilla, L., & Rossi, D. (2021) · Cells · doi:10.3390/cells10030518 · Cited by 42
Cortical hyperexcitability and the split-hand plus phenomenon: Pathophysiological insights in ALS
Bae, J. S., Menon, P., Mioshi, E., Kiernan, M. C., & Vucic, S. (2014) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2013.872150 · Cited by 42
MRI Texture Analysis Reveals Deep Gray Nuclei Damage in Amyotrophic Lateral Sclerosis
de Albuquerque, M., Anjos, L., de Andrade, H. M. T., de Oliveira, M. S., Castellano, G., de Rezende, T. J. R., Nucci, A., & França, M. C. (2015) · Journal of Neuroimaging · doi:10.1111/jon.12262 · Cited by 42
Amyotrophic Lateral Sclerosis, a Multisystem Pathology: Insights into the Role of TNF α
Tortarolo, M., Coco, D. L., Veglianese, P., Vallarola, A., Giordana, M. T., Marcon, G., Beghi, E., Poloni, M., Strong, M. J., Iyer, A. M., et al. (2017) · Mediators of Inflammation · doi:10.1155/2017/2985051 · Cited by 43
Interleukin-6 and amyotrophic lateral sclerosis
Pronto‐Laborinho, A. C., Pinto, S., Gromicho, M., Pereira, M., Swash, M., & de Carvalho, M. A. (2019) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2019.01.026 · Cited by 42
Potential of activated microglia as a source of dysregulated extracellular microRNAs contributing to neurodegeneration in amyotrophic lateral sclerosis
Christoforidou, E., Joilin, G., & Hafezparast, M. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01822-4 · Cited by 44
A systematic comparison of kinetic modelling methods generating parametric maps for [11C]-(R)-PK11195
Anderson, A. N., Pavese, N., Edison, P., Tai, Y., Hammers, A., Gerhard, A., Brooks, D. J., & Turkheimer, F. (2007) · NeuroImage · doi:10.1016/j.neuroimage.2007.02.017 · Cited by 42
Self-citation
Whole-body distribution and metabolism of [N-methyl-11C](R)-1-(2-chlorophenyl)-N-(1-methylpropyl)-3-isoquinolinecarboxamide in humans; an imaging agent for in vivo assessment of peripheral benzodiazepine receptor activity with positron emission tomography
Roivainen, A., Någren, K., Hirvonen, J., Oikonen, V., Virsu, P., Tolvanen, T., & Rinne, J. O. (2008) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-008-1000-1 · Cited by 42
The Frontotemporal Syndromes of ALS. Clinicopathological Correlates
Strong, M. J., & Yang, W. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9609-0 · Cited by 41
Ghrelin Protects Spinal Cord Motoneurons Against Chronic Glutamate Excitotoxicity by Inhibiting Microglial Activation
Lee, S., Kim, Y., Li, E., & Park, S. (2012) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.2012.16.1.43 · Cited by 41
The innate and adaptive immunological aspects in neurodegenerative diseases
Rodrigues, M. C. O., Sanberg, P. R., Cruz, L. E. G., & Garbuzova-Davis, S. N. (2013) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2013.09.020 · Cited by 42
HuR promotes the molecular signature and phenotype of activated microglia: Implications for amyotrophic lateral sclerosis and other neurodegenerative diseases
Matsye, P. D., Zheng, L., Si, Y., Kim, S., Luo, W., Crossman, D. K., Bratcher, P. E., & King, P. H. (2017) · Glia · doi:10.1002/glia.23137 · Cited by 44
Therapeutic Strategies Under Development Targeting Inflammatory Mechanisms in Amyotrophic Lateral Sclerosis
Crisafulli, S. G., Brajkovic, S., Mis, M. S. C., Parente, V., & Corti, S. P. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0532-4 · Cited by 41
Neurosteroid Metabolites of Gonadal Steroid Hormones in Neuroprotection: Implications for Sex Differences in Neurodegenerative Disease
Mendell, A. L., & MacLusky, N. J. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00359 · Cited by 46
Microglia as therapeutic targets after neurological injury: strategy for cell therapy
Scott, M. C., Bedi, S. S., Olson, S. D., Sears, C. M., & Cox, C. S. (2021) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2021.1934447 · Cited by 43
Frontotemporal degeneration in amyotrophic lateral sclerosis (ALS): a longitudinal MRI one-year study
Trojsi, F., Nardo, F. D., Siciliano, M., Caiazzo, G., Femiano, C., Passaniti, C., Ricciardi, D., Russo, A., Bisecco, A., Esposito, S., et al. (2020) · CNS Spectrums · doi:10.1017/s109285292000005x · Cited by 41
Neuroimaging in primary lateral sclerosis
Pioro, E. P., Turner, M. R., & Bede, P. (2020) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2020.1837176 · Cited by 40
Self-citation
Frontotemporal Pathology in Motor Neuron Disease Phenotypes: Insights From Neuroimaging
McKenna, M. C., Corcia, P., Couratier, P., Siah, W. F., Pradat, P., & Bede, P. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.723450 · Cited by 40
Inter- and Intracellular Signaling in Amyotrophic Lateral Sclerosis: Role of p38 Mitogen-Activated Protein Kinase
Bendotti, C., Cutrona, M. B., Cheroni, C., Grignaschi, G., Coco, D. L., Peviani, M., Tortarolo, M., Veglianese, P., & Zennaro, E. (2005) · Neurodegenerative Diseases · doi:10.1159/000089617 · Cited by 39
Sulfhydryl-mediated redox signaling in inflammation: role in neurodegenerative diseases
Miller, O. G., & Mieyal, J. J. (2015) · Archives of Toxicology · doi:10.1007/s00204-015-1496-7 · Cited by 40
Imaging Neuroinflammation – from Bench to Bedside
Pulli, B. (2014) · Journal of Clinical & Cellular Immunology · doi:10.4172/2155-9899.1000226 · Cited by 41
Brain functional connectome abnormalities in amyotrophic lateral sclerosis are associated with disability and cortical hyperexcitability
Geevasinga, N., Korgaonkar, M. S., Menon, P., van den Bos, M. A. J., Gomes, L., Foster, S., Kiernan, M. C., & Vucic, S. (2017) · European Journal of Neurology · doi:10.1111/ene.13461 · Cited by 39
Novel PET Imaging of Inflammatory Targets and Cells for the Diagnosis and Monitoring of Giant Cell Arteritis and Polymyalgia Rheumatica
van der Geest, K. S. M., Sandovici, M., Nienhuis, P. H., Slart, R. H. J. A., Heeringa, P., Brouwer, E., & Jiemy, W. F. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.902155 · Cited by 39
ERK1/2-dependent TSPO overactivation associates with the loss of mitophagy and mitochondrial respiration in ALS
Magrì, A., Lipari, C. L. R., Risiglione, P., Zimbone, S., Guarino, F., Caccamo, A., & Messina, A. A. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05643-0 · Cited by 40
Wnt Signaling Alterations in the Human Spinal Cord of Amyotrophic Lateral Sclerosis Cases: Spotlight on Fz2 and Wnt5a
González‐Fernández, C., González, P., Andrés‐Benito, P., Ferrer, I., & Rodríguez, F. J. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-1547-9 · Cited by 37
Inflammatory mediators and growth factors in the spinal cord of G93A SOD1 rats
Xie, Y., Weydt, P., Howland, D., Kliot, M., & Möller, T. (2004) · Neuroreport · doi:10.1097/00001756-200411150-00016 · Cited by 38
The diagnosis of Amyotrophic lateral sclerosis in 2010.
Silani, V., Messina, S., Poletti, B., Morelli, C., Doretti, A., Ticozzi, N., & Maderna, L. (2011) · PubMed · doi:10.4449/aib.v149i1.1260 · Cited by 38
Motor and extramotor neurodegeneration in amyotrophic lateral sclerosis: A 3T high angular resolution diffusion imaging (HARDI) study
Trojsi, F., Corbo, D., Caiazzo, G., Piccirillo, G., Monsurrò, M. R., Cirillo, S., Esposito, F., & Tedeschi, G. (2013) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2013.785569 · Cited by 37
Neuroimaging as a New Diagnostic Modality in Amyotrophic Lateral Sclerosis
Verstraete, E., & Foerster, B. R. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0347-9 · Cited by 36
PET imaging studies show enhanced expression of mGluR5 and inflammatory response during progressive degeneration in ALS mouse model expressing SOD1-G93A gene
Brownell, A., Kuruppu, D., Kil, K.-E., Jokivarsi, K. T., Poutiainen, P., Zhu, A., & Maxwell, M. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0439-9 · Cited by 37
A pilot trial of RNS60 in amyotrophic lateral sclerosis
Paganoni, S., Alshikho, M. J., Luppino, S. D., Chan, J. G. M., Pothier, L. M., Schoenfeld, D., Andres, P. L., Babu, S., Zürcher, N. R., Loggia, M. L., et al. (2018) · Muscle & Nerve · doi:10.1002/mus.26385 · Cited by 39
The TSPO Ligands 2-Cl-MGV-1, MGV-1, and PK11195 Differentially Suppress the Inflammatory Response of BV-2 Microglial Cell to LPS
Azrad, M., Zeineh, N., Weizman, A., Veenman, L., & Gavish, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030594 · Cited by 37
Neurodegeneration: Diagnosis, Prevention, and Therapy
Poddar, M. K., Chakraborty, A., & Banerjee, S. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.94950 · Cited by 40
GABAA-receptor mRNA expression in the prefrontal and temporal cortex of ALS patients
Petri, S., Kollewe, K., Grothe, C., Hori, A., Dengler, R., Bufler, J., & Krampfl, K. (2006) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2006.08.005 · Cited by 37
Genetic validation of a therapeutic target in a mouse model of ALS
de Boer, A. S., Koszka, K., Kiskinis, E., Suzuki, N., Davis‐Dusenbery, B. N., & Eggan, K. C. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3009351 · Cited by 35
Review: Microglia in protein aggregation disorders: friend or foe?
Gentleman, S. (2013) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12017 · Cited by 38
Imaging of glia activation in people with primary lateral sclerosis
Paganoni, S., Alshikho, M. J., Zürcher, N. R., Cernasov, P., Babu, S., Loggia, M. L., Chan, J. G. M., Chonde, D. B., Izquierdo‐Garcia, D., Catana, C., et al. (2017) · NeuroImage Clinical · doi:10.1016/j.nicl.2017.10.024 · Cited by 36
Cerebellar tract alterations in PLS and ALS
Tu, S., Menke, R., Talbot, K., Kiernan, M. C., & Turner, M. R. (2019) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2018.1562554 · Cited by 36
Self-citation
Therapeutic actions of translocator protein (18 kDa) ligands in experimental models of psychiatric disorders and neurodegenerative diseases
Arbo, B. D., Benetti, F., García‐Segura, L. M., & Ribeiro, M. F. M. (2015) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2015.07.007 · Cited by 40
Diffusion Tensor Imaging of Basal Ganglia and Thalamus in Amyotrophic Lateral Sclerosis
Sharma, K. R., Sheriff, S., Maudsley, A. A., & Govind, V. (2012) · Journal of Neuroimaging · doi:10.1111/j.1552-6569.2011.00679.x · Cited by 38
Cortical activation to voluntary movement in amyotrophic lateral sclerosis is related to corticospinal damage: electrophysiological evidence.
Riva, N., Falini, A., Inuggi, A., González-Rosa, J., Amadio, S., Cerri, F., Fazio, R., Carro, U. D., Comola, M., Comi, G., et al. (2012) · Clinical Neurophysiology · doi:10.1016/j.clinph.2011.12.013 · Cited by 35
Brain MR Imaging in Patients with Lower Motor Neuron–Predominant Disease
Spinelli, E. G., Agosta, F., Ferraro, P. M., Riva, N., Lunetta, C., Falzone, Y., Comı, G., Falini, A., & Filippi, M. (2016) · Radiology · doi:10.1148/radiol.2016151846 · Cited by 36
Evaluation of Methods for Generating Parametric ( R )-[ 11 C]PK11195 Binding Images
Schuitemaker, A., van Berckel, B. N. M., Kropholler, M. A., Kloet, R. W., Jonker, C., Scheltens, P., Lammertsma, A. A., & Boellaard, R. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600459 · Cited by 36
Early focality and spread of cortical dysfunction in amyotrophic lateral sclerosis: A regional study across the motor cortices
Dharmadasa, T., Matamala, J. M., Howells, J., Vucic, S., & Kiernan, M. C. (2019) · Clinical Neurophysiology · doi:10.1016/j.clinph.2019.11.057 · Cited by 35
Gut microbiota immune cross-talk in amyotrophic lateral sclerosis
Kaul, M., Mukherjee, D., Weiner, H. L., & Cox, L. M. (2024) · Neurotherapeutics · doi:10.1016/j.neurot.2024.e00469 · Cited by 36
The Role of Neuroinflammation in Neurodegenerative Disorders
Suescun, J., Chandra, S., & Schiess, M. C. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813832-8.00013-3 · Cited by 34
Neurochemical biomarkers in amyotrophic lateral sclerosis
Verde, F., Silani, V., & Otto, M. (2019) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000744 · Cited by 36
Targeting the CB2 receptor and other endocannabinoid elements to delay disease progression in amyotrophic lateral sclerosis
Rodríguez‐Cueto, C., García‐Toscano, L., Santos‐García, I., Gómez‐Almería, M., Gonzalo‐Consuegra, C., Espejo‐Porras, F., Fernández‐Ruíz, J., & de Lago, E. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15386 · Cited by 34
Biomarker development for C9orf72 repeat expansion in ALS
Mendez, E. F., & Sattler, R. (2014) · Brain Research · doi:10.1016/j.brainres.2014.09.041 · Cited by 34
Activin A concentrations in human cerebrospinal fluid are age-dependent and elevated in meningitis
Ebert, S., Phillips, D. J., Jenzewski, P., Nau, R., O’Connor, A. E., & Michel, U. (2006) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2006.06.026 · Cited by 34
The role of immune-mediated alterations and disorders in ALS disease
Rodrigues Lima-Junior, J., Sulzer, D., Lindestam Arlehamn, C. S., & Sette, A. (2021) · Human Immunology · doi:10.1016/j.humimm.2021.01.017 · Cited by 33
Accumulation of altered aspartyl residues in erythrocyte membrane proteins from patients with sporadic amyotrophic lateral sclerosis
D’Angelo, S., Trojsi, F., Salvatore, A., Daniele, L., Raimo, M., Galletti, P., & Monsurrò, M. R. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2013.09.006 · Cited by 33
Positron Emission Tomography Imaging of Neuroinflammation
Kannan, S., Balakrishnan, B., Muzik, O., Romero, R. J., & Chugani, D. C. (2009) · Journal of Child Neurology · doi:10.1177/0883073809338063 · Cited by 33
Pathophysiology and Treatment of Non-motor Dysfunction in Amyotrophic Lateral Sclerosis
Mahoney, C., Ahmed, R. M., Huynh, W., Tu, S., Rohrer, J. D., Bedlack, R., Hardiman, O. M., & Kiernan, M. C. (2021) · CNS Drugs · doi:10.1007/s40263-021-00820-1 · Cited by 38
Identification of a Misfolded Region in Superoxide Dismutase 1 That Is Exposed in Amyotrophic Lateral Sclerosis
Rotunno, M. S., Auclair, J. R., Maniatis, S., Shaffer, S. A., Agar, J. N., & Bosco, D. A. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.581801 · Cited by 33
Diffusion tensor imaging patterns differ in bulbar and limb onset amyotrophic lateral sclerosis
Prell, T., Peschel, T., Hartung, V., Kaufmann, J., Klauschies, R., Bodammer, N., Kollewe, K., Dengler, R., & Großkreutz, J. (2012) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2012.11.031 · Cited by 33
Testing the diagnostic accuracy of [18F]FDG-PET in discriminating spinal- and bulbar-onset amyotrophic lateral sclerosis
Sala, A., Iaccarino, L., Fania, P., Vanoli, E. G., Fallanca, F., Pagnini, C., Cerami, C., Calvo, A., Canosa, A., Pagani, M., et al. (2019) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-018-4246-2 · Cited by 33
Guanosine Inhibits CD40 Receptor Expression and Function Induced by Cytokines and β Amyloid in Mouse Microglia Cells
D’Alimonte, I., Flati, V., D’Auro, M., Toniato, E., Martinotti, S., Rathbone, M. P., Jiang, S., Ballerini, P., Iorio, P. D., Caciagli, F., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.2.720 · Cited by 32
Retracted
Role of matrix metalloproteinase-9 in a mouse model for amyotrophic lateral sclerosis
Dewil, M., Schurmans, C. L., Starckx, S., Opdenakker, G., Bosch, L. V. D., & Robberecht, W. (2005) · Neuroreport · doi:10.1097/00001756-200503150-00003 · Cited by 32
Identical patterns of cortico-efferent tract involvement in primary lateral sclerosis and amyotrophic lateral sclerosis: A tract of interest-based MRI study
Müller, H., Gorges, M., Kassubek, R., Dorst, J., Ludolph, A. C., & Kassubek, J. (2018) · NeuroImage Clinical · doi:10.1016/j.nicl.2018.03.018 · Cited by 31
Vitamin D supplementation has no effects on progression of motor dysfunction in amyotrophic lateral sclerosis (ALS)
Trojsi, F., Siciliano, M., Passaniti, C., Bisecco, A., Russo, A., Lavorgna, L., Esposito, S., Ricciardi, D., Monsurrò, M. R., Tedeschi, G., et al. (2019) · European Journal of Clinical Nutrition · doi:10.1038/s41430-019-0448-3 · Cited by 31
Regional motor cortex dysfunction in amyotrophic lateral sclerosis
Menon, P., Yiannikas, C., Kiernan, M. C., & Vucic, S. (2019) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.50819 · Cited by 31
Neuroinflammation in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia and the Interest of Induced Pluripotent Stem Cells to Study Immune Cells Interactions With Neurons
Liu, E., Karpf, L., & Bohl, D. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.767041 · Cited by 32
Oligoclonal bands in the cerebrospinal fluid of amyotrophic lateral sclerosis patients with disease-associated mutations
Ticozzi, N., Tiloca, C., Mencacci, N. E., Morelli, C., Doretti, A., Rusconi, D., Colombrita, C., Sangalli, D., Verde, F., Finelli, P., et al. (2012) · Journal of Neurology · doi:10.1007/s00415-012-6589-0 · Cited by 31
Dissociation of blood-brain barrier disruption and disease manifestation in an aquaporin-4-deficient mouse model of amyotrophic lateral sclerosis
Watanabe-Matsumoto, S., Moriwaki, Y., Okuda, T., Ohara, S., Yamanaka, K., Abe, Y., Yasui, M., & Misawa, H. (2017) · Neuroscience Research · doi:10.1016/j.neures.2017.11.001 · Cited by 31
Magnetization Transfer Imaging Demonstrates a Distributed Pattern of Microstructural Changes of the Cerebral Cortex in Amyotrophic Lateral Sclerosis
Cosottini, M., Pesaresi, I., Piazza, S., Diciotti, S., Belmonte, G., Battaglini, M., Ginestroni, A., Siciliano, G., Stefano, N. D., & Mascalchi, M. (2011) · American Journal of Neuroradiology · doi:10.3174/ajnr.a2356 · Cited by 30
Novel Neuroprotective Multicomponent Therapy for Amyotrophic Lateral Sclerosis Designed by Networked Systems
Herrando‐Grabulosa, M., Mulet‐Lazaro, R., Pujol, A., Mas, J. M., Navarro, X., Aloy, P., Coma, M., & Casas, C. (2016) · PLoS ONE · doi:10.1371/journal.pone.0147626 · Cited by 30
Theory of Mind and Its Neuropsychological and Quality of Life Correlates in the Early Stages of Amyotrophic Lateral Sclerosis
Trojsi, F., Siciliano, M., Russo, A., Passaniti, C., Femiano, C., Ferrantino, T., Liguoro, S. D., Lavorgna, L., Monsurrò, M. R., Tedeschi, G., et al. (2016) · Frontiers in Psychology · doi:10.3389/fpsyg.2016.01934 · Cited by 30
Fasciculation intensity and disease progression in amyotrophic lateral sclerosis
Tsugawa, J., Dharmadasa, T., Ma, Y., Huynh, W., Vucic, S., & Kiernan, M. C. (2018) · Clinical Neurophysiology · doi:10.1016/j.clinph.2018.07.015 · Cited by 31
Amyotrophic lateral sclerosis diagnostic index
Geevasinga, N., Howells, J., Menon, P., van den Bos, M. A. J., Shibuya, K., Matamala, J. M., Park, S. B., Byth, K., Kiernan, M. C., & Vucic, S. (2019) · Neurology · doi:10.1212/wnl.0000000000006876 · Cited by 29
A Therapeutic Strategy for Alzheimer's Disease Focused on Immune-inflammatory Modulation
Kim, S. H., Noh, M., Kim, H.-J., Oh, K., Park, J., Lee, S.-G., Moon, Y., Kim, Y.-E., Bae, J. S., Jin, H. K., et al. (2019) · Dementia and Neurocognitive Disorders · doi:10.12779/dnd.2019.18.2.33 · Cited by 30
Hippocampal connectivity in Amyotrophic Lateral Sclerosis (ALS): more than Papez circuit impairment
Trojsi, F., Nardo, F. D., Caiazzo, G., Siciliano, M., D’Alvano, G., Ferrantino, T., Passaniti, C., Ricciardi, D., Esposito, S., Lavorgna, L., et al. (2020) · Brain Imaging and Behavior · doi:10.1007/s11682-020-00408-1 · Cited by 30
Brain Metabolism and Microglia Activation in Mild Cognitive Impairment: A Combined [18F]FDG and [11C]-(R)-PK11195 PET Study
Tondo, G., Boccalini, C., Caminiti, S. P., Presotto, L., Filippi, M., Magnani, G., Frisoni, G. B., Iannaccone, S., & Perani, D. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201351 · Cited by 29
Degeneration of the Mid-Cingulate Cortex in Amyotrophic Lateral Sclerosis Detected In Vivo with MR Spectroscopy
Sudharshan, N., Hanstock, C. C., Hui, B., Pyra, T., Johnston, W. S. W., & Kalra, S. (2010) · American Journal of Neuroradiology · doi:10.3174/ajnr.a2289 · Cited by 30
(Micro)Glia as Effectors of Cortical Volume Loss in Schizophrenia
Mallya, A. P., & Deutch, A. Y. (2018) · Schizophrenia Bulletin · doi:10.1093/schbul/sby088 · Cited by 30
Assessing anxiety and its correlates in amyotrophic lateral sclerosis: The state‐trait anxiety inventory
Siciliano, M., Trojano, L., Trojsi, F., Monsurrò, M. R., Tedeschi, G., & Santangelo, G. (2019) · Muscle & Nerve · doi:10.1002/mus.26475 · Cited by 32
New insights on the disease contribution of neuroinflammation in amyotrophic lateral sclerosis
Chiot, A., Lobsiger, C. S., & Boillée, S. (2019) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000729 · Cited by 34
A rare CACNA1H variant associated with amyotrophic lateral sclerosis causes complete loss of Cav3.2 T-type channel activity
Stringer, R. N., Jurkovičová-Tarabová, B., Huang, S., Haji‐Ghassemi, O., Idoux, R., Liashenko, A., Souza, I. A., Rzhepetskyy, Y., Lacinová, Ľ., Petegem, F. V., et al. (2020) · Molecular Brain · doi:10.1186/s13041-020-00577-6 · Cited by 29
Microglia in ALS: Insights into Mechanisms and Therapeutic Potential
Bond, S., Saxena, S., & Sierra-Delgado, J. A. (2025) · Cells · doi:10.3390/cells14060421 · Cited by 32
Ca2+-activated K+ channels modulate microglia affecting motor neuron survival in hSOD1G93A mice
Cocozza, G., Castro, M. A. D., Carbonari, L., Grimaldi, A., Antonangeli, F., Garofalo, S., Porzia, A., Madonna, M., Mainiero, F., Santoni, A., et al. (2018) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2018.07.002 · Cited by 29
Structural MRI outcomes and predictors of disease progression in amyotrophic lateral sclerosis
Spinelli, E. G., Riva, N., Rancoita, P. M. V., Schito, P., Doretti, A., Poletti, B., Serio, C. D., Silani, V., Filippi, M., & Agosta, F. (2020) · NeuroImage Clinical · doi:10.1016/j.nicl.2020.102315 · Cited by 27
Microglial crosstalk with astrocytes and immune cells in amyotrophic lateral sclerosis
Calafatti, M., Cocozza, G., Limatola, C., & Garofalo, S. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1223096 · Cited by 29
Neuroinflammatory Pathways in the ALS-FTD Continuum: A Focus on Genetic Variants
Marchi, F. D., Tondo, G., Corrado, L., Menegon, F., Aprile, D., Anselmi, M., D’Alfonso, S., Comi, C., & Mazzini, L. (2023) · Genes · doi:10.3390/genes14081658 · Cited by 31
Chapter 13 Amyotrophic lateral sclerosis
Leigh, P. N. (2007) · Handbook of clinical neurology · doi:10.1016/s0072-9752(07)80016-9 · Cited by 28
Self-citation
SPM analysis of parametric (R)-[11C]PK11195 binding images: Plasma input versus reference tissue parametric methods
Schuitemaker, A., van Berckel, B. N. M., Kropholler, M. A., Veltman, D. J., Scheltens, P., Jonker, C., Lammertsma, A. A., & Boellaard, R. (2007) · NeuroImage · doi:10.1016/j.neuroimage.2007.02.013 · Cited by 28
A comparison of in vitro properties of resting SOD1 transgenic microglia reveals evidence of reduced neuroprotective function
Sargsyan, S. A., Blackburn, D. J., Barber, S. C., Großkreutz, J., Vos, K. J. D., Monk, P. N., & Shaw, P. J. (2011) · BMC Neuroscience · doi:10.1186/1471-2202-12-91 · Cited by 28
Frontotemporal Cortical Thinning in Amyotrophic Lateral Sclerosis
d'Ambrosio, A., Gallo, A., Trojsi, F., Corbo, D., Esposito, F., Cirillo, M., Monsurrò, M. R., & Tedeschi, G. (2013) · American Journal of Neuroradiology · doi:10.3174/ajnr.a3753 · Cited by 28
Whole Body Biodistribution and Radiation Dosimetry in Humans of a New PET Ligand, [18F]-FEPPA, to Image Translocator Protein (18 kDa)
Mizrahi, R., Rusjan, P., Vitcu, I., Ng, A., Wilson, A. A., Houle, S., & Bloomfield, P. M. (2012) · Molecular Imaging and Biology · doi:10.1007/s11307-012-0589-4 · Cited by 28
The (Endo)Cannabinoid System in Multiple Sclerosis and Amyotrophic Lateral Sclerosis
Centonze, D., Rossi, S., Finazzi‐Agrò, A., Bernardi, G., & Maccarrone, M. (2007) · International review of neurobiology · doi:10.1016/s0074-7742(07)82009-5 · Cited by 29
Targeting common disease pathomechanisms to treat amyotrophic lateral sclerosis
Faller, K. M. E., Chaytow, H., & Gillingwater, T. H. (2025) · Nature Reviews Neurology · doi:10.1038/s41582-024-01049-4 · Cited by 30
Brain Stimulation as a Therapeutic Tool in Amyotrophic Lateral Sclerosis: Current Status and Interaction With Mechanisms of Altered Cortical Excitability
Ranieri, F., Mariotto, S., Dubbioso, R., & Lazzaro, V. D. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2020.605335 · Cited by 28
Association of Cortical Hyperexcitability and Cognitive Impairment in Patients With Amyotrophic Lateral Sclerosis
Higashihara, M., Pavey, N., van den Bos, M. A. J., Menon, P., Kiernan, M. C., & Vucic, S. (2021) · Neurology · doi:10.1212/wnl.0000000000011798 · Cited by 26
Complex Inflammation mRNA-Related Response in ALS Is Region Dependent
Berjaoui, S., Povedano, M., Garcia‐Esparcia, P., Carmona, M., Aso, E., & Ferrer, I. (2015) · Neural Plasticity · doi:10.1155/2015/573784 · Cited by 28
Morphometric and neurochemical alterations found in l-BMAA treated rats
de Munck, E., Muñoz‐Sáez, E., Miguel, B. G., Solas, M. T., Martínez, A., & Arahuetes, R. M. (2015) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2015.04.022 · Cited by 27
Neuroinflammation and Neurodegeneration
Morales, I., Farias, G. A., Cortés, N., & Maccioni, R. B. (2016) · InTech eBooks · doi:10.5772/64545 · Cited by 34
Neuronal over-expression of Oxr1 is protective against ALS-associated mutant TDP-43 mislocalisation in motor neurons and neuromuscular defects in vivo
Williamson, M. G., Finelli, M. J., Sleigh, J. N., Reddington, A., Gordon, D., Talbot, K., Davies, K. E., & Oliver, P. L. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddz190 · Cited by 28
Transient middle cerebral artery occlusion induces microglial priming in the lumbar spinal cord: a novel model of neuroinflammation
Moisse, K., Welch, I. D., Hill, T. L., Volkening, K., & Strong, M. J. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-29 · Cited by 27
Brain Metabolites and Peripheral Biomarkers Associated with Neuroinflammation in Complex Regional Pain Syndrome Using [11C]-(R)-PK11195 Positron Emission Tomography and Magnetic Resonance Spectroscopy: A Pilot Study
Jung, Y.-H., Kim, H., Jeon, S. Y., Kwon, J. M., Lee, W. J., Kim, Y. C., Jang, J. H., Choi, S., Lee, J., & Kang, D. (2018) · Pain Medicine · doi:10.1093/pm/pny111 · Cited by 26
Imaging inflammation and its resolution in health and disease: current status, clinical needs, challenges, and opportunities
Liu, C. H., Abrams, N., Carrick, D. M., Chander, P., Dwyer, J. T., Hamlet, M. R. J., Kindzelski, A., PrabhuDas, M., Tsai, S., Vedamony, M. M., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201902024 · Cited by 26
The high affinity peripheral benzodiazepine receptor ligand DAA1106 binds to activated and infected brain macrophages in areas of synaptic degeneration: Implications for PET imaging of neuroinflammation in lentiviral encephalitis
Venneti, S., Wang, G., & Wiley, C. A. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.08.016 · Cited by 26

Authors: Turner, M. R., Cagnin, A., Turkheimer, F. E., Miller, C. C. J., Shaw, C. E., Brooks, D. J., Leigh, P. N., & Banati, R. B.
Affiliations: King's College London (GB)
University of Padua (IT)
Hammersmith Hospital (GB)
Corresponding author: Turner, M.R
ORCID: Turner, M.R
Turkheimer, F.E
Miller, C.C.J
Shaw, C.E
Brooks, D.J
Banati, R.B
Venue: Neurobiology of Disease
Publisher: Elsevier BV
Published: 2004-04
Volume: 15
Issue: 3
Pages: 601-609
ISSN: 0969-9961 (ISSN-L)
DOI: 10.1016/j.nbd.2003.12.012
OpenAlex: W2019706623
Cited by: 737
References: 90
Citations by year: 2026: 15 · 2025: 23 · 2024: 37 · 2023: 31 · 2022: 40 · 2021: 52 · 2020: 52 · 2019: 43 · 2018: 43 · 2017: 44 · 2016: 42 · 2015: 42 · 2014: 47 · 2013: 42 · 2012: 27
FWCI: 15.87
Type: journal article
Language: en
Open access: green
doaj.org
Licence: cc-by-sa
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Neurobiology of Disease (publishedVersion)
PubMed (publishedVersion)
DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Research Portal (King's College London) (submittedVersion)
Padua Research Archive (University of Padova) (submittedVersion, other-oa)
Topics: Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
Keywords: amyotrophic lateral sclerosis, microglial activation, [11C]PK11195, positron emission tomography, translocator protein (TSPO), motor cortex, passive optical networks, dorsolateral prefrontal cortex, thalamus, upper motor neuron signs, neuroinflammation, neuropathology
MeSH terms: Adult, Amyotrophic Lateral Sclerosis, Brain, Female, Humans, Isoquinolines, Male, Middle Aged, Tomography, Emission-Computed, Microglia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks